NDC 51662-1459

AMIDATE(TM) ETOMIDATE

Amidate(tm) Etomidate

AMIDATE(TM) ETOMIDATE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Etomidate.

Product ID51662-1459_a227d2f1-3ef0-4ac6-e053-2995a90a5340
NDC51662-1459
Product TypeHuman Prescription Drug
Proprietary NameAMIDATE(TM) ETOMIDATE
Generic NameAmidate(tm) Etomidate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-03-31
Marketing CategoryNDA / NDA
Application NumberNDA018227
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameETOMIDATE
Active Ingredient Strength2 mg/mL
Pharm ClassesGeneral Anesthesia [PE],General Anesthetic [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51662-1459-1

10 mL in 1 VIAL, SINGLE-USE (51662-1459-1)
Marketing Start Date2020-03-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1459-1 [51662145901]

AMIDATE(TM) ETOMIDATE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-03-31

Drug Details

Active Ingredients

IngredientStrength
ETOMIDATE2 mg/mL

OpenFDA Data

SPL SET ID:a227d2f1-3eef-4ac6-e053-2995a90a5340
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1654006
  • Pharmacological Class

    • General Anesthesia [PE]
    • General Anesthetic [EPC]

    NDC Crossover Matching brand name "AMIDATE(TM) ETOMIDATE" or generic name "Amidate(tm) Etomidate"

    NDCBrand NameGeneric Name
    51662-1455AMIDATE(TM) ETOMIDATEAMIDATE(TM) ETOMIDATE
    51662-1459AMIDATE(TM) ETOMIDATEAMIDATE(TM) ETOMIDATE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.